Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Gavras

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Hypertension (Dallas, Tex. : 1979)|December 1, 1995
Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertensionO Kohlmann, M Ginoza, M L Cezaretti, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Role of substance P in blood pressure regulation in salt-dependent experimental hypertensionO Kohlmann, M L Cesaretti, M Ginoza, et al.
Kidney & Blood Pressure Research|October 13, 2006
Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?L C Martin, R J S Franco, I Gavras, et al.
American Journal of Hypertension|December 21, 2004
Association between hypervolemia and ventricular hypertrophy in hemodialysis patientsL C Martin, R J S Franco, I Gavras, et al.
American Journal of Human Genetics|October 30, 1998
Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18qA L DeStefano, C T Baldwin, M Burzstyn, et al.
American Journal of Hypertension|October 6, 1999
Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertensionC T Baldwin, F Schwartz, J Baima, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Hypertension (Dallas, Tex. : 1979)|December 1, 1995
Cardiovascular effects of a specific nonpeptide antagonist of substance P (NK-1) receptor in DOCA-salt hypertensionO Kohlmann, M Ginoza, M L Cezaretti, et al.
Hypertension (Dallas, Tex. : 1979)|January 1, 1997
Role of substance P in blood pressure regulation in salt-dependent experimental hypertensionO Kohlmann, M L Cesaretti, M Ginoza, et al.
Kidney & Blood Pressure Research|October 13, 2006
Is 44-hour better than 24-hour ambulatory blood pressure monitoring in hemodialysis?L C Martin, R J S Franco, I Gavras, et al.
American Journal of Hypertension|December 21, 2004
Association between hypervolemia and ventricular hypertrophy in hemodialysis patientsL C Martin, R J S Franco, I Gavras, et al.
American Journal of Human Genetics|October 30, 1998
Autosomal dominant orthostatic hypotensive disorder maps to chromosome 18qA L DeStefano, C T Baldwin, M Burzstyn, et al.
American Journal of Hypertension|October 6, 1999
Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertensionC T Baldwin, F Schwartz, J Baima, et al.
Pageof 17